Evidence map›Paper›PMID 40421658›Full record

ArticleBriefings in bioinformatics2025

MambaPhase: deep learning for liquid-liquid phase separation protein classification.

Jianwei Huang, Youli Zhang, Shulin Ren, Ziyang Wang, Xiaocheng Jin, Xiaoli Lu, Yu Zhang, Xiaoping Min, Shengxiang Ge, Jun Zhang and 1 more

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jianwei HuangInstitute of Artificial Intelligence, School of Informatics, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Youli ZhangNational Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Shulin RenState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Ziyang WangInstitute of Artificial Intelligence, School of Informatics, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Xiaocheng JinNational Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Xiaoli LuInformation and Networking Center, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Yu ZhangInstitute of Artificial Intelligence, School of Informatics, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Xiaoping MinInstitute of Artificial Intelligence, School of Informatics, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Shengxiang GeNational Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Jun ZhangNational Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.
Ningshao XiaNational Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, No. 422 Siming South Rd, 361005, Xiamen, Fujian, China.

Funding

Fundamental Research Funds the Central Universities 20720220006Major Science and Technology Project of Fujian Provincial Health Commission 20212ZD01006National Natural Science Foundation of China 62272399Special Funds for Basic Research Operating Costs of Central Universities 20720220005the Noncommunicable Chronic: Diseases-National Science and Technology Major Project 2023ZD05 01001
6 · The paper itself

Abstract

Liquid-liquid phase separation plays a critical role in cellular processes, including protein aggregation and RNA metabolism, by forming membraneless subcellular structures. Accurate identification of phase-separated proteins is essential for understanding and controlling these processes. Traditional identification methods are effective but often costly and time-consuming. The recent machine learning methods have reduced these costs, but most models are restricted to classifying scaffold and client proteins with limited experimental conditions. To address this limitation, we developed a Mamba-based encoder using contrastive learning that incorporates separation probability, protein type, and experimental conditions. Our model achieved 95.2% accuracy in predicting phase-separated proteins and an ROCAUC score of 0.87 in classifying scaffold and client proteins. Further validation in the DgHBP-2 drug delivery system demonstrated its potential for condition modulation in drug development. This study provides an effective framework for the accurate identification and control of phase separation, facilitating advancements in biomedical research and therapeutic applications.

Indexed as

Deep LearningProteinsHumansPhase SeparationProteinsdrug deliveryliquid–liquid phase separation (LLPS)machine learningprotein phase separation

Identifiers

PMID40421658
PMCPMC12107247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.